Literature DB >> 10403806

Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes.

J Liu1, C A Kuszynski, B T Baxter.   

Abstract

Tetracyclines have been used in the treatment of chronic inflammatory diseases associated with local infiltration of inflammatory cells and matrix destruction as observed in rheumatoid arthritis and periodontal disease. Fas/Fas ligand (FasL)-mediated apoptosis plays an important role in maintaining T lymphocyte homeostasis and modulating immune response. The present study demonstrates that doxycycline inhibits Jurkat T lymphocyte proliferation and induces apoptosis. The phytohemagglutinin (PHA)-activated Jurkat cells are more susceptible to doxycycline-induced apoptosis. Furthermore, doxycycline-induced apoptosis is associated with increased Fas/FasL expression in Jurkat cells. The increase of apoptosis in Jurkat cells treated with doxycycline is consistent with the increase of FasL expression. These results suggest that doxycycline may downregulate the inflammatory process in certain diseases by eliminating activated T lymphocytes through Fas/FasL-mediated apoptosis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403806     DOI: 10.1006/bbrc.1999.0929

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Nonhealing wound due to Rhodococcus equi in an apparently immunocompetent patient, revealing CD8+ T-lymphocyte deficiency.

Authors:  Eric Denes; Dominique Peignon-Orsoni; François-Xavier Terrade
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

2.  Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells.

Authors:  Jiunn-Min Shieh; Tur-Fu Huang; Chi-Feng Hung; Kuan-Hsien Chou; Yih-Jeng Tsai; Wen-Bin Wu
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites.

Authors:  Christina Spry; Christina L L Chai; Kiaran Kirk; Kevin J Saliba
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.

Authors:  Alka Prasad; Michael Lu; David M Lukac; Steven L Zeichner
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite.

Authors:  Kevin J Saliba; Isabelle Ferru; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  In vitro effects of ciprofloxacin and roxithromycin on apoptosis of jurkat T lymphocytes.

Authors:  Yong-Taek Jun; Hee-Jung Kim; Min-Jin Song; Ji-Hyang Lim; Dong-Gun Lee; Kyung-Ja Han; Su-Mi Choi; Jin-Hong Yoo; Wan-Shik Shin; Jung-Hyun Choi
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 7.  The eye: a window of opportunity in rheumatoid arthritis?

Authors:  Louis Tong; Julian Thumboo; York Kiat Tan; Tien-Yin Wong; Salvatore Albani
Journal:  Nat Rev Rheumatol       Date:  2014-06-10       Impact factor: 20.543

8.  Involvement of glycoreceptors in galactoxylomannan-induced T cell death.

Authors:  Eva Pericolini; Elena Gabrielli; Elio Cenci; Magdia De Jesus; Francesco Bistoni; Arturo Casadevall; Anna Vecchiarelli
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Low concentrations of doxycycline attenuates FasL-induced apoptosis in HeLa cells.

Authors:  Jung Mi Yoon; Sushruta Koppula; Se Jong Huh; Sun Jin Hur; Chan Gil Kim
Journal:  Biol Res       Date:  2015-07-24       Impact factor: 5.612

10.  Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid.

Authors:  David J Gould; Carly Bright; Yuti Chernajovsky
Journal:  Arthritis Res Ther       Date:  2003-12-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.